35 related articles for article (PubMed ID: 19968719)
1. Retraction notice to "Furowanin A-induced autophagy alleviates apoptosis and promotes cell cycle arrest via inactivation STAT3/Mcl-1 axis in colorectal cancer" [Life Sci. 218 (2019) 47-57].
Ma Z; Bao X; Gu J
Life Sci; 2024 May; 344():122587. PubMed ID: 38521622
[No Abstract] [Full Text] [Related]
2. Selective drug combination vulnerabilities in STAT3- and TP53-mutant malignant NK cells.
Parri E; Kuusanmäki H; Bulanova D; Mustjoki S; Wennerberg K
Blood Adv; 2021 Apr; 5(7):1862-1875. PubMed ID: 33792631
[TBL] [Abstract][Full Text] [Related]
3. Structural Implications of STAT3 and STAT5 SH2 Domain Mutations.
de Araujo ED; Orlova A; Neubauer HA; Bajusz D; Seo HS; Dhe-Paganon S; Keserű GM; Moriggl R; Gunning PT
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31717342
[TBL] [Abstract][Full Text] [Related]
4. Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3.
Lu T; Bankhead A; Ljungman M; Neamati N
Theranostics; 2019; 9(19):5478-5496. PubMed ID: 31534498
[TBL] [Abstract][Full Text] [Related]
5. LEE011 and ruxolitinib: a synergistic drug combination for natural killer/T-cell lymphoma (NKTCL).
Hee YT; Yan J; Nizetic D; Chng WJ
Oncotarget; 2018 Aug; 9(61):31832-31841. PubMed ID: 30159126
[TBL] [Abstract][Full Text] [Related]
6. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Kuusanmäki H; Dufva O; Parri E; van Adrichem AJ; Rajala H; Majumder MM; Yadav B; Parsons A; Chan WC; Wennerberg K; Mustjoki S; Heckman CA
Oncotarget; 2017 Nov; 8(57):97516-97527. PubMed ID: 29228628
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma.
Park S; Lim J; Kim JR; Cho S
J Vet Sci; 2017 Dec; 18(4):419-429. PubMed ID: 28385009
[TBL] [Abstract][Full Text] [Related]
9. A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3/STAT3 signaling pathway.
Mao Y; Wang J; Zhang M; Fan W; Tang Q; Xiong S; Tang X; Xu J; Wang L; Yang S; Liu S; Xu L; Chen Y; Xu L; Yin R; Zhu J
Oncotarget; 2017 Feb; 8(7):10954-10965. PubMed ID: 28009988
[TBL] [Abstract][Full Text] [Related]
10. STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma.
Mizowaki T; Sasayama T; Tanaka K; Mizukawa K; Takata K; Nakamizo S; Tanaka H; Nagashima H; Nishihara M; Hirose T; Itoh T; Kohmura E
J Neurooncol; 2015 Sep; 124(2):165-74. PubMed ID: 26080800
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.
Marozin S; Altomonte J; Muñoz-Álvarez KA; Rizzani A; De Toni EN; Thasler WE; Schmid RM; Ebert O
Cancer Gene Ther; 2015 Jun; 22(6):317-25. PubMed ID: 25930184
[TBL] [Abstract][Full Text] [Related]
12. The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity.
Thompson RC; Vardinogiannis I; Gilmore TD
PLoS One; 2013; 8(5):e62822. PubMed ID: 23667527
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition.
Quoc Trung L; Espinoza JL; Takami A; Nakao S
PLoS One; 2013; 8(1):e55183. PubMed ID: 23372833
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells.
Espinoza JL; Takami A; Trung LQ; Kato S; Nakao S
PLoS One; 2012; 7(12):e51306. PubMed ID: 23251493
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor regulates Mcl-1 expression through the MAPK-Elk-1 signalling pathway contributing to cell survival in breast cancer.
Booy EP; Henson ES; Gibson SB
Oncogene; 2011 May; 30(20):2367-78. PubMed ID: 21258408
[TBL] [Abstract][Full Text] [Related]
16. Frequent STAT3 activation is associated with Mcl-1 expression in nasal NK-cell lymphoma.
Tsutsui M; Yasuda H; Suto H; Imai H; Isobe Y; Sasaki M; Kojima Y; Oshimi K; Sugimoto K
Int J Lab Hematol; 2010 Aug; 32(4):419-26. PubMed ID: 19968719
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma.
Yasuda H; Sugimoto K; Imai H; Isobe Y; Sasaki M; Kojima Y; Nakamura S; Oshimi K
Eur J Haematol; 2009 Jan; 82(1):39-45. PubMed ID: 18778369
[TBL] [Abstract][Full Text] [Related]
18. Effects of a JAK inhibitor, AG490, on proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2Z.
Wu MH; Chen XY; Cai KR
Ai Zheng; 2009 Jan; 28(1):24-8. PubMed ID: 19448411
[TBL] [Abstract][Full Text] [Related]
19. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
